Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Ticklel1ston Oct 18, 2021 1:30am
136 Views
Post# 34016690

RE:AGM and voting

RE:AGM and voting4hand. 
A majority of public companies’ shares (70-80%) are held in “street name” – Shares held in “street name” are held of record through The Depository Trust and Clearing Corporation (DTCC) by participant broker-dealer and banks who, in turn, hold shares on behalf of their clients, the individual beneficial owners – The “street name” system was developed in stages over the last 40 years to replace physical exchange of certificates and checks, and underlies the US market's ability to handle tremendous trading volumes, encourage greatly increased participation in the capital markets and support significant innovation in financial products • As the “legal” owner of shares, only the shareholder of record has voting rights – Upon the record date established for a company’s annual meeting (identifying those holders eligible to vote), DTCC provides a list of broker-dealers, banks and other institutions that hold the company’s shares in street name and issues an “omnibus proxy” to transfer the voting rights to these participants – Street name or beneficial shareholders do not have direct voting rights – Beneficial shareholders, generally by contract with their bank or broker, have the right to provide ‘voting instructions’ to their bank or broker, who, in turn, has the legal right to actually vote those shares
<< Previous
Bullboard Posts
Next >>